Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Assets Average: 2021-2025

Historic Assets Average for CureVac N.V (CVAC) over the last 3 years, with Jun 2025 value amounting to $780.3 million.

  • CureVac N.V's Assets Average rose 15.62% to $780.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $780.3 million, marking a year-over-year increase of 15.62%. This contributed to the annual value of $853.0 million for FY2024, which is 1.16% down from last year.
  • As of Q2 2025, CureVac N.V's Assets Average stood at $780.3 million, which was down 4.77% from $819.3 million recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Assets Average peaked at $2.1 billion during Q3 2021, and registered a low of $674.9 million during Q2 2024.
  • Over the past 3 years, CureVac N.V's median Assets Average value was $851.0 million (recorded in 2023), while the average stood at $854.5 million.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 53.85% in 2022, then increased by 15.62% in 2025.
  • CureVac N.V's Assets Average (Quarterly) stood at $1.6 billion in 2021, then crashed by 45.35% to $898.0 million in 2022, then declined by 1.71% to $882.7 million in 2023, then increased by 1.74% to $898.0 million in 2024, then grew by 15.62% to $780.3 million in 2025.
  • Its last three reported values are $780.3 million in Q2 2025, $819.3 million for Q1 2025, and $898.0 million during Q4 2024.